Escalating adjuvant treatment based on ctDNA positivity does not improve RFS in patients with stage III colon cancer, data suggest.

A reflex ctDNA-methylation MCED test can detect multiple cancer types in patients with obesity, a new study suggests.

A training platform integrated with AI can help pathologists identify HER2-low and HER2-ultralow breast cancers with more accuracy, data suggest.

Adding perioperative systemic therapy to CRS-HIPEC can improve some outcomes in patients with resectable colorectal peritoneal metastases, data suggest.

A symptom assessment intervention can reduce acute care use and costs for older adults with cancer, a study suggests.

The worse overall survival seen in transgender and gender-diverse patients may be due to treatment differences or non-breast cancer causes, researchers say.

HHS Secretary Robert F. Kennedy Jr. said this week that he may no longer allow government scientists to publish research in top medical journals.

Patritumab deruxtecan demonstrated activity against brain metastases and leptomeningeal disease in a phase 2 trial of patients with advanced cancers.

The FDA has accepted for priority review the new drug application for sevabertinib (BAY 2927088) to treat certain patients with NSCLC.

The results of this phase III KEYNOTE-991 study do not support the addition of pembrolizumab to enzalutamide and ADT for the treatment of mHSPC,” researchers wrote.

As of this writing, the role of PD-L1 inhibitors in prostate cancer remains limited to a subset of patients with metastatic microsatellite instability-high, mismatch repair-deficient, or tumor ...

On May 20, the US Department of Health and Human Services (HHS) announced that recommending COVID-19 vaccinations for healthy children and pregnant patients would no longer be routine. “I couldn’t be ...